Quantitative Measurement of Anti-SARS-CoV-2 Antibodies: Analytical and Clinical Evaluation
Top Cited Papers
- 19 March 2021
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 59 (4)
- https://doi.org/10.1128/jcm.03149-20
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19). While molecular-based testing is used to diagnose COVID-19, serologic testing of antibodies specific to SARS-CoV-2 is used to detect past infection.Keywords
This publication has 15 references indexed in Scilit:
- Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19The New England Journal of Medicine, 2020
- Waiting for Certainty on Covid-19 Antibody Tests - At What Cost?The New England Journal of Medicine, 2020
- Disappearance of antibodies to SARS-CoV-2 in a -COVID-19 patient after recoveryClinical Microbiology & Infection, 2020
- Antibody tests for identification of current and past infection with SARS-CoV-2Emergencias, 2020
- Antibody responses to SARS-CoV-2 in patients with COVID-19Nature Medicine, 2020
- Ten reasons why immunity passports are a bad ideaNature, 2020
- Assay Techniques and Test Development for COVID-19 DiagnosisACS Central Science, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019Clinical Infectious Diseases, 2020
- Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmissionScience China Life Sciences, 2020